Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

May 31, 1999

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

Cancer

Interventions

DRUG

XRP6976 (Docetaxel/Taxotere)

Trial Locations (6)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Buenos Aires

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Porto Salvo

Sanofi-Aventis Administrative Office, Moscow